Loading...
Jupiter Neurosciences, Inc.
JUNS•NASDAQ
Healthcare
Biotechnology
$1.24
$0.22(21.08%)
Jupiter Neurosciences, Inc. (JUNS) Financial Performance & Statements
Review Jupiter Neurosciences, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
20.14%
↑ 20.14%
Net Income Growth
49.001%
↑ 49.001%
Operating Cash Flow Growth
-713.18%
↓ 713.18%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
344.69%
↑ 344.69%
ROIC
-131.69%
↓ 131.69%
Jupiter Neurosciences, Inc. (JUNS) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Jupiter Neurosciences, Inc. stock.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Cash & Cash Equivalents | $2.71M | $3.77M | $253.00 | $14851.00 |
Short Term Investments | $0.00 | $0.00 | $0.00 | $0.00 |
Cash & Short Term Investments | $2.71M | $3.77M | $253.00 | $14851.00 |
Net Receivables | $0.00 | $0.00 | $0.00 | $0.00 |
Inventory | $0.00 | $0.00 | $0.00 | $0.00 |
Other Current Assets | $904859.00 | $880753.00 | $261.00 | $25261.00 |
Total Current Assets | $3.61M | $4.65M | $514.00 | $40112.00 |
Property Plant & Equipment (Net) | $58035.00 | $69642.00 | $81249.00 | $92856.00 |
Goodwill | $0.00 | $0.00 | $0.00 | $0.00 |
Intangible Assets | $0.00 | $0.00 | $0.00 | $0.00 |
Goodwill & Intangible Assets | $0.00 | $0.00 | $0.00 | $0.00 |
Long Term Investments | $0.00 | $0.00 | $0.00 | $0.00 |
Tax Assets | $0.00 | $0.00 | $0.00 | $0.00 |
Other Non-Current Assets | $1.29M | $1.48M | $3783.00 | $3783.00 |
Total Non-Current Assets | $1.35M | $1.55M | $85032.00 | $96639.00 |
Total Assets | $4.96M | $6.20M | $85546.00 | $136751.00 |
Account Payables | $0.00 | $278676.00 | $205795.00 | $200283.00 |
Short Term Debt | $196988.00 | $196514.00 | $2.21M | $2.18M |
Tax Payables | $0.00 | $0.00 | $0.00 | $0.00 |
Deferred Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Other Current Liabilities | $1.69M | $1.53M | $3.27M | $2.95M |
Total Current Liabilities | $1.89M | $2.009M | $5.68M | $5.33M |
Long Term Debt | $8507.00 | $21247.00 | $155686.00 | $163333.00 |
Deferred Revenue Non-Current | $0.00 | $0.00 | $0.00 | $0.00 |
Deferred Tax Liabilities Non-Current | $0.00 | $0.00 | $0.00 | $0.00 |
Other Non-Current Liabilities | $0.00 | $0.00 | $0.00 | $0.00 |
Total Non-Current Liabilities | $8507.00 | $21247.00 | $155686.00 | $163333.00 |
Capital Lease Obligations | $59063.00 | $71329.00 | $83570.00 | $95786.00 |
Total Liabilities | $1.90M | $2.03M | $5.84M | $5.49M |
Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 |
Common Stock | $3310.00 | $3310.00 | $3012.00 | $3012.00 |
Retained Earnings | -$27.55M | -$26.02M | -$24.49M | -$23.90M |
Accumulated Other Comprehensive Income/Loss | $0.00 | $0.00 | $0.00 | $0.00 |
Total Stockholders Equity | $3.06M | $4.17M | -$5.75M | -$5.36M |
Total Equity | $0.00 | $4.17M | -$5.75M | -$5.36M |
Total Liabilities & Stockholders Equity | $4.96M | $6.20M | $85546.00 | $136751.00 |
Total Investments | $0.00 | $0.00 | $0.00 | $0.00 |
Total Debt | $205495.00 | $217761.00 | $2.36M | $2.34M |
Net Debt | -$2.50M | -$3.55M | $2.36M | $2.33M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan